← back to search

Mahmoud Ghandi

Broad Institute · US
Area of research
Molecular Biology · Pathology and Forensic Medicine
Research interest
Research interests include Cancer Mechanisms and Therapy, Genomics and Chromatin Dynamics, RNA modifications and cancer, and Melanoma and MAPK Pathways.
h-index
26
citations
29,003
works
93
NIH funding
primary concept
Biology
email

Recent publications

RPL22 is a tumor suppressor in MSI-high cancers and a splicing regulator of MDM4
Cell Reports 2024cited by 19position: middledoi
Targeted in silico characterization of fusion transcripts in tumor and normal tissues via FusionInspector
Cell Reports Methods 2023cited by 30position: middledoi
Quantitative Proteomics of the Cancer Cell Line Encyclopedia
Cell 2020cited by 1,036position: middledoi
Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs
Cell 2020cited by 277position: middledoi
Multiplexed single-cell transcriptional response profiling to define cancer vulnerabilities and therapeutic mechanism of action
Nature Communications 2020cited by 180position: middledoi
Next-generation characterization of the Cancer Cell Line Encyclopedia
Nature 2019cited by 3,669position: firstdoi
The landscape of cancer cell line metabolism
Nature Medicine 2019cited by 571position: middledoi
WRN helicase is a synthetic lethal target in microsatellite unstable cancers
Nature 2019cited by 466position: middledoi
Multiplexed single-cell profiling of post-perturbation transcriptional responses to define cancer vulnerabilities and therapeutic mechanism of action
bioRxiv (Cold Spring Harbor Laboratory) 2019cited by 5position: middledoi
Genetic and transcriptional evolution alters cancer cell line drug response
Nature 2018cited by 935position: middledoi
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
Nature Communications 2018cited by 113position: middledoi
Defining a Cancer Dependency Map
Cell 2017cited by 3,422position: middledoi
Allele-Specific DNA Methylation and Its Interplay with Repressive Histone Marks at Promoter-Mutant TERT Genes
Cell Reports 2017cited by 83position: middledoi
Decomposing Oncogenic Transcriptional Signatures to Generate Maps of Divergent Cellular States
Cell Systems 2017cited by 53position: middledoi
gkmSVM: an R package for gapped-kmer SVM
Bioinformatics 2016cited by 211position: firstdoi
Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations
Blood 2016cited by 157position: middledoi
Characterizing genomic alterations in cancer by complementary functional associations
Nature Biotechnology 2016cited by 111position: middledoi
Suppression of 19S proteasome subunits marks emergence of an altered cell state in diverse cancers
Proceedings of the National Academy of Sciences 2016cited by 57position: middledoi
The Molecular Signatures Database Hallmark Gene Set Collection
Cell Systems 2015cited by 14,236position: middledoi
Enhanced Regulatory Sequence Prediction Using Gapped k-mer Features
PLoS Computational Biology 2014cited by 570position: firstdoi
ARID1B is a specific vulnerability in ARID1A-mutant cancers
Nature Medicine 2014cited by 427position: middledoi
Locally Disordered Methylation Forms the Basis of Intratumor Methylome Variation in Chronic Lymphocytic Leukemia
Cancer Cell 2014cited by 413position: middledoi
Punctuated Evolution of Prostate Cancer Genomes
Cell 2013cited by 1,350position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Levi A. Garraway · Cancer Research Center8 papers (2014–2020)Francisca Vázquez · Universidade de Santiago de Compostela6 papers (2014–2024)Gregory V. Kryukov · Q Therapeutics (United States)4 papers (2014–2020)Aviad Tsherniak · Massachusetts Institute of Technology4 papers (2017–2020)Todd R. Golub · Broad Institute3 papers (2017–2020)Aviv Regev · Moscow Institute of Thermal Technology3 papers (2019–2023)William C. Hahn · University of California System3 papers (2014–2019)Andrew J. Aguirre · Harvard University3 papers (2014–2020)Emily S. Chambers · Harvard University2 papers (2019–2020)Donna Neuberg · Massachusetts General Hospital2 papers (2014–2016)Itay Tirosh · American Committee for the Weizmann Institute of Science2 papers (2019–2020)Olena Kuksenko · Broad Institute2 papers (2019–2020) · 2 papers (2019–2020)Danielle Dionne · Broad Institute2 papers (2019–2020)Brian M. Wolpin · Harvard University2 papers (2019–2020)Andrew Jones · Princeton University2 papers (2019–2020)Jennifer A. Roth · Broad Institute2 papers (2019–2020) · 2 papers (2014–2016)Tsukasa Shibue · Massachusetts Institute of Technology2 papers (2019–2020)M Beer · Directorate-General for Interpretation2 papers (2014–2016)